Leadership Spotlight: From Formulation to Manufacture with Dipak Gordhan
Discover more about our team. In this Leadership Spotlight, meet our Associate Director of Manufacturing Operations, Dipak Gordhan on his journey with Upperton.
Menu
News
Upperton Pharma Solutions Adds Large-Scale Processing following MHRA Approval at Nottingham Facility
Upperton Pharma Solutions Adds Large-Scale Processing following MHRA Approval at Nottingham Facility, Trent Gateway.
Upperton wins Outstanding Achievement at Medilink UK National Healthcare Business Awards 2024
Upperton win’s Outstanding Achievement at Medilink UK National Healthcare Business Awards 2024 for Trent Gateway facility build.
Project Management Spotlight with Charlie Wright
Discover more about our team. In this Leadership Spotlight, meet our Associate Director of Project Management, Charlie Wright, and learn more about her journey with Upperton and unique approach to project management.
Upperton Recognised in Sunday Times 100 Fastest-Growing Companies 2024
We’re honoured to announce that Upperton has been recognised as one of the Sunday Times’ 100 fastest-growing companies in the UK for 2024.
Scientist Spotlight: A Journey of Innovation with Shailesh Mistry
Discover more about our team. In this Scientist Spotlight:, meet our Development Manager, Shailesh Mistry on his journey with Upperton.
Dry Powder Formulation: The Next Generation
Outlining the Trends and Challenges in the Inhaled Drug Delivery Market, with a Special Focus on Dry Powder Formulation.
Upperton Joined by Professor Dame Sarah Gilbert, To Officially Open New Development and GMP Manufacturing Facility.
Upperton Joined by Professor Dame Sarah Gilbert, To Officially Open New Development and GMP Manufacturing Facility.
Upperton appoint Philip Payne as Chief Commercial Officer
Upperton Pharma Solutions continues growth with the appointment of Philip Payne as Chief Commercial Officer.
Upperton announces expansion into sterile drug manufacturing with new £5million GMP facility
Upperton Pharma Solutions has announced a £5million investment to expand operations into small-scale sterile fill-finish.
